Biotech & Pharma companies have a data problem. Biomedical datasets and scientific literature are densely full of knowledge and quickly growing. Even as scientists get more and more specialized, it is difficult and resource intensive for organizations to remain up to date with emerging and evolving information.
ERGO allows scientists to extract insights to make meaningful discoveries from the world’s biomedical knowledge.
Explore what is known about a biomedical entity such as a gene, disease, or drug, to answer questions and discover new connections. Proprietary data can be integrated to put results in context of what is known. ERGO creates a unified set of analysis and ML-ready biomedical data to accelerate and de-risk drug development pipelines, especially in target validation, for biomedical teams needing faster, actionable insights from the vast set of biomedical data.
From strategy to deployment, we partner with you where you are in the AI/ML lifecycle.